Qualitative Interviews to Support Development and Cognitive Debriefing of the Adelphi Adherence Questionnaire (ADAQ©): A Patient-Reported Measure of Medication Adherence Developed for Use in a Range of Diseases, Treatment Modalities, and Countries
Sarah Bentley,Lucy Morgan,Elizabeth Exall,Rob Arbuckle,Rebecca C Rossom,Nicholas Roche,Kamlesh Khunti,Victoria Higgins,James Piercy
DOI: https://doi.org/10.2147/PPA.S358046
2022-09-15
Patient Preference and Adherence
Abstract:Sarah Bentley, 1 Lucy Morgan, 1 Elizabeth Exall, 1 Rob Arbuckle, 1 Rebecca C Rossom, 2 Nicholas Roche, 3 Kamlesh Khunti, 4 Victoria Higgins, 5 James Piercy 5 1 Patient-Centered Outcomes, Adelphi Values, Bollington, Cheshire, UK; 2 HealthPartners Institute, University of Minnesota Medical School, Minneapolis, MN, USA; 3 Respiratory Medicine, Cochin Hospital, APHP Centre University Paris Cité, Institut Cochin (UMR1016), Paris, France; 4 Diabetes Research Centre, Leicester University, Leicester, UK; 5 Adelphi Real World, Bollington, Cheshire, UK Correspondence: Rob Arbuckle, Patient-Centered Outcomes, Adelphi Values, Bollington, Cheshire, UK, Tel +44 7720 880884, Email Purpose: The Adelphi Adherence Questionnaire (ADAQ©) is a newly developed generic patient-reported outcome (PRO) assessment of medication adherence. The aim was to assess its content validity by conducting cognitive debriefing (CD) interviews with patients prescribed medication(s) of various treatment modalities in a range of therapy areas. Materials and Methods: Targeted literature/instrument review and concept elicitation interviews informed development of the ADAQ©. CD interviews were conducted with 57 adults from the United States of America (USA; n = 21), Spain (n = 18), and Germany (n = 18) who prescribed medication for hypertension, diabetes, depression, schizophrenia, asthma, multiple myeloma, psoriasis, and/or multiple sclerosis. Interviews were conducted in two rounds to explore the relevance and understanding of the item wording, instructions, recall period and response options. Verbatim transcripts were analysed in ATLAS.Ti using thematic analysis. Three expert clinicians provided guidance throughout the study. Results: ADAQ© items/instructions were well understood and relevant to participants. Key modifications following round 1 included revising instructions to refer to current medication(s) for one condition to reduce cognitive burden, removing two items with lower relevance (specifically those assessing running out of medication and social discouragement), and adding a response option for participants to indicate if they had stopped taking a medication. Minor wording modifications were made following round 2. Subgroup differences in item relevance were explored based on clinical characteristics. Cost of medication was more relevant amongst US participants. Conclusion: Content validity of the ADAQ© was confirmed in demographically and clinically diverse participants. Psychometric properties of the ADAQ© will be explored in future studies. Keywords: patient-reported outcome development, qualitative research, adherence, cognitive debriefing Adherence to medications has been defined as the extent to which a patient takes medication as prescribed and in correspondence with agreed recommendations from the prescribing healthcare professional (HCP). 1,2 Alternatively, and more specifically, it has been defined as the process by which patients take their medications as prescribed, 3 including timing, dose and interval of medication intake. 3–5 Unlike the outdated term compliance (which focuses on the patient taking medication as instructed by the HCP), the concept of medication adherence takes into account the influence of many interrelated factors on adherence, including patient factors (lifestyle, personality, attitudes, etc.) and the influence of HCPs, the healthcare system and the environment/society in general. 5–7 Medication adherence is essential for optimising patient care, and achieving desired clinical goals and outcomes. 1,8,9 Medication non-adherence can negatively impact a treatment's beneficial effects, which may result in greater healthcare costs and mortality, and worsening of patients' health. 10 Despite these adverse outcomes, medication non-adherence is widespread; it is estimated that 20% of patients intentionally temporarily stop taking their prescription medication. 1 Further, the World Health Organization estimates that up to 50% of patients prescribed medication for chronic conditions take their medication less than 80% of the time. 1,11 Gaining an understanding of the extent of and reasons for non-adherence can enable HCPs to engage in effective communication with patients and efficient treatment planning to improve medication adherence, thereby improving patient care and health outcomes. Common forms of non-adherence reported in the literature include skipping a dose of medication, taking a different amount of medication than prescribed, and taking medication at a different time of day than prescribed. 1,12 -Abstract Truncated-
medicine, general & internal